CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Beactica is focused on creating a treatment for glioblastoma, a severe brain tumor, by developing a compound that inhibits the LSD1 protein. This innovative approach aims to improve patient outcomes and reduce the economic burden of ineffective treatments.
The goal of this project is to develop a successful treatment that combats the progression of glioblastoma and improve patients’ quality of life.
Glioblastoma, the most malignant brain tumour, leads to disproportionately high morbidity in patients and impacts the economy through high mortality rates.
The available treatment options are highly ineffective and pose a significant challenge to the healthcare budgets of all nations.Beactica aims to address this challenge by developing novel compound…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
